Vorinostat (NSC# 701852) in patients with relapsed non-small cell lung cancer: a Wisconsin Oncology Network phase II study. [electronic resource]
Producer: 20090630Description: 522-6 p. digitalISSN:- 1556-1380
- Aged
- Antineoplastic Agents -- therapeutic use
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Enzyme Inhibitors -- therapeutic use
- Female
- Histone Deacetylase Inhibitors
- Humans
- Hydroxamic Acids -- adverse effects
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Neoplasm Recurrence, Local -- drug therapy
- Vorinostat
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.